Javier de Diego-Adeliño

6PUBLICATIONS
38CO-AUTHORS
PharmacogenomicsEpidemiological methodsClinical neuropsychologyOrthodontics and dentofacial orthopaedicsSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 18, 2025
The DEPRE'5 study: pragmatic, multicentre, five-arm, parallel-group randomised controlled trial with blinded assessment to compare treatment strategies in major depression after a failed selective serotonin reuptake inhibitor treatment.

Víctor Pérez, Dolors Puigdemont, Javier de Diego-Adeliño

|Mar 19, 2025
A Real-World Study on the Use, Effectiveness, and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression: INTEGRATE Study.

Patricio Molero, Angela Ibañez, Javier de Diego-Adeliño

|Oct 19, 2023
If you feel you can't, you won't: the role of subjective and objective cognitive competence on psychosocial functioning in depression.

Muriel Vicent-Gil, Joan Trujols, Maria Serra-Blasco

|Jul 05, 2023
Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS).

Ángel Oteo-Álvaro, Carlos Goicoechea García, Alejandra Inocencio Sánchez

|Dec 29, 2021
Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review.

Javier De Diego-Adeliño, José Manuel Crespo, Fernando Mora

|Jan 25, 2017
Lack of relationship between plasma levels of escitalopram and QTc-interval length.

Mar Carceller-Sindreu, Javier de Diego-Adeliño, Maria J Portella

Pageof 1

Frequent Collaborators

2 joint publications

Carlo Alemany Santamaria

1 joint publications

Fernando Mora

1 joint publications

Pedro Iborra

1 joint publications

Luis Gutiérrez-Rojas